Domiciliary Use of Hyaluronic Acid Gel Solutions vs Domiciliary Use of Chlorhexidine Mouthwash 0,20% for the Management of Periodontal Patients
Primary Purpose
Periodontal Diseases
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Aftoral Oral gel
Unidea Chlorhexidine digluconate mouthwash 0.20%
Sponsored by

About this trial
This is an interventional treatment trial for Periodontal Diseases
Eligibility Criteria
Inclusion Criteria:
- presence of periodontitis sites with PPD > 5 mm
- no systemic, metabolic and autoimmune disease
- compliant patients
Exclusion Criteria:
- neurologic, psychiatric and mental diseases
- patients taking bisphosphonates in the last 12 months
- patients taking antibiotics during the study
- pregnant and breastfeeding women
- patients undergoing anticancer treatment
Sites / Locations
- Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Trial Group
Control Group
Arm Description
Home treatment with hyaluronic acid.
Home treatment with chlorhexidine.
Outcomes
Primary Outcome Measures
Change in Probing Pocket Depth (PPD)
Evaluation (in mm) of the depth of the gingival sulcus, through a millimeter periodontal probe; it is detected from the gingival margin to the bottom of the gingival sulcus or periodontal pocket, evaluated at 6 sites.
Gingival Recession (R)
Evaluation (in mm) of the displacement of marginal tissue, through a millimeter periodontal probe; it is detected from the cemento-enamel junction (CEJ) to the gingival margin.
Change in Bleeding on Probing (BOP%)
Quantitative assessment (percentage) of the bleeding sites (6 per tooth in total).
Formula = n ° bleeding sites / n ° probed sites x100
Change in Clinical Attachment Level (CAL)
Evaluation (in mm) of the distance of the cemento-enamel junction (CEJ) to the bottom of the gingival sulcus or periodontal pocket, evaluated in 6 sites.
Change in Plaque Control Record (PCR%)
Evaluation of the presence of plaque on the 4 surfaces of teeth on the total amount of dental surfaces.
Formula = n ° sites with plaque / total n ° of dental surfaces x100
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05312606
Brief Title
Domiciliary Use of Hyaluronic Acid Gel Solutions vs Domiciliary Use of Chlorhexidine Mouthwash 0,20% for the Management of Periodontal Patients
Official Title
Domiciliary Use of Hyaluronic Acid Gel Solutions vs Domiciliary Use of Chlorhexidine Mouthwash 0,20% for the Management of Periodontal Patients: a Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Completed
Study Start Date
April 4, 2022 (Actual)
Primary Completion Date
November 1, 2022 (Actual)
Study Completion Date
November 5, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pavia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Brief Summary: This is a randomized controlled clinical trial (RCT). After signing the informed consent, patients satisfying the inclusion criteria will undergo supragingival and subgingival professional oral hygiene of both arches performed with ultrasonic instrumentation, manual instrumentation with Gracey curettes and air polishing with glycine powder.
After that, the sample will be randomly divided into 2 groups based on the domiciliary assigned treatment:
Aftoral® Oral Gel solution with Hyaluronic Acid, Xylitol and glycerophosphoinositol as a domiciliary application for 15 days.
Unidea® Chlorhexidine digluconate Mouthwash 0,20% administration as a domiciliary application for 15 days.
The study will last 6 months. Patients will be visited at: T0, after 1 month from T0 (T1), after 3 months (T2), after 6 months (T3). Professional hygiene will be performed again at T2 and T3.
At each recall session were collected a satisfaction questionnaire of the products (taste, smell, consistency, persistence and ease of application) and the following periodontal clinical indices, using a Periodontal probe on each site:
Gingival Recession (R)
PPD (Probing Pocket Depth),
BOP% (Bleeding on Probing),
CAL (Clinical Attachment Level),
PCR% (Plaque Control Record),
Tooth Mobility.
Detailed Description
This is a randomized controlled clinical trial (RCT). 40 patients are expected to be enrolled. After signing the informed consent, patients satisfying the inclusion criteria will undergo supragingival and subgingival professional oral hygiene of both arches performed with ultrasonic instrumentation, manual instrumentation with Gracey curettes and air polishing with glycine powder.
All patients will be treated at the Unit of Dental Hygiene, Section of Dentistry, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences of the University of Pavia.
After that, the sample will be randomly divided into 2 groups based on the domiciliary assigned treatment:
Aftoral® Oral Gel solution with Hyaluronic Acid, Xylitol and glycerophosphoinositol as a domiciliary application for 15 days.
Unidea® Chlorhexidine digluconate Mouthwash 0,20% administration as a domiciliary application for 15 days.
The study will last 6 months. Patients will be visited at: T0, after 1 month from T0 (T1), after 3 months (T2), and after 6 months (T3).
At T2 and T3, professional hygiene will be performed again.
At each recall session were collected a satisfaction questionnaire of the products (taste, smell, consistency, persistence and ease of application) and the following periodontal clinical indices, using a Periodontal probe on each site:
Gingival Recession (R),
PPD (Probing Pocket Depth),
BOP% (Bleeding on Probing),
CAL (Clinical Attachment Level),
PCR% (Plaque Control Record),
Tooth Mobility.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Periodontal Diseases
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Trial Group
Arm Type
Experimental
Arm Description
Home treatment with hyaluronic acid.
Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
Home treatment with chlorhexidine.
Intervention Type
Other
Intervention Name(s)
Aftoral Oral gel
Intervention Description
Patients will use Aftoral® Oral Gel solution for the domiciliary application once a day for 15 days after the visits (no rinsing and eating for 30 minutes after gel solution application).
Intervention Type
Other
Intervention Name(s)
Unidea Chlorhexidine digluconate mouthwash 0.20%
Intervention Description
Patients will use chlorhexidine mouthwash 0,20% for the domiciliary application once a day for 15 days after the visits (no rinsing and eating for 30 minutes after mouthwash application).
Primary Outcome Measure Information:
Title
Change in Probing Pocket Depth (PPD)
Description
Evaluation (in mm) of the depth of the gingival sulcus, through a millimeter periodontal probe; it is detected from the gingival margin to the bottom of the gingival sulcus or periodontal pocket, evaluated at 6 sites.
Time Frame
Baseline (T0), after 1 (T1), 3 (T2) and 6 months (T3)
Title
Gingival Recession (R)
Description
Evaluation (in mm) of the displacement of marginal tissue, through a millimeter periodontal probe; it is detected from the cemento-enamel junction (CEJ) to the gingival margin.
Time Frame
Baseline (T0), after 1 (T1), 3 (T2) and 6 months (T3)
Title
Change in Bleeding on Probing (BOP%)
Description
Quantitative assessment (percentage) of the bleeding sites (6 per tooth in total).
Formula = n ° bleeding sites / n ° probed sites x100
Time Frame
Baseline (T0), after 1 (T1), 3 (T2) and 6 months (T3)
Title
Change in Clinical Attachment Level (CAL)
Description
Evaluation (in mm) of the distance of the cemento-enamel junction (CEJ) to the bottom of the gingival sulcus or periodontal pocket, evaluated in 6 sites.
Time Frame
Baseline (T0), after 1 (T1), 3 (T2) and 6 months (T3)
Title
Change in Plaque Control Record (PCR%)
Description
Evaluation of the presence of plaque on the 4 surfaces of teeth on the total amount of dental surfaces.
Formula = n ° sites with plaque / total n ° of dental surfaces x100
Time Frame
Baseline (T0), after 1 (T1), 3 (T2) and 6 months (T3)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
presence of periodontitis sites with PPD > 5 mm
no systemic, metabolic and autoimmune disease
compliant patients
Exclusion Criteria:
neurologic, psychiatric and mental diseases
patients taking bisphosphonates in the last 12 months
patients taking antibiotics during the study
pregnant and breastfeeding women
patients undergoing anticancer treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andrea Scribante, DDS, PhD, MS
Organizational Affiliation
University of Pavia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia
City
Pavia
State/Province
Lombardy
ZIP/Postal Code
27100
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Data are available upon motivated request to the Principal Investigator.
Learn more about this trial
Domiciliary Use of Hyaluronic Acid Gel Solutions vs Domiciliary Use of Chlorhexidine Mouthwash 0,20% for the Management of Periodontal Patients
We'll reach out to this number within 24 hrs